4SCAR-GD2 / SZGIMI - LARVOL DELTA

Study on GD2 Positive Solid Tumors by 4SCAR-GD2 (clinicaltrials.gov) - P1/2 | N=10 | Not yet recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | N=100 ➔ 10

Enrollment change • Oncology • Solid Tumor

Study on GD2 Positive Solid Tumors by 4SCAR-GD2 (clinicaltrials.gov) - P1/2 | N=100 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial primary completion date: Jun 2019 ➔ Jun 2028 | Unknown status ➔ Recruiting | Trial completion date: Dec 2020 ➔ Dec 2029

Enrollment open • Trial completion date • Trial primary completion date • Solid Tumor